Lung Ultrasound
Diagnostic TestLung ultrasound will be performed on patients undergoing investigation for covid-19 based on a nasopharyngeal PCR.
NCT Number: NCT04384055
This study seeks to investigate the role of lung ultrasound in caring for Covid-19 positive patients and whether it can be used to predict patient deterioration. This information will be vital for healthcare workers who seek to identify Covid-19 pneumonia or patients at risk for deterioration early in the disease course.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
University of California San Francisco, San Francisco, California, United States
As Covid-19 continues to stress hospital-based resources (including personal protective equipment, ancillary staff availability, and imaging study utilization), it is important to assess whether alternative methods for evaluating patients can be utilized to appropriately triage and care for Covid-positive patients. Current limitations of caring for patients with Covid-19 include the exposure of ancillary healthcare workers (including radiological technicians) and the time/resources required to decontaminate traditional radiological equipment such as x-ray or computerized tomography (CT) machines.
Point-of-care ultrasound (POCUS) has the potential to transform healthcare delivery due to its diagnostic and therapeutic expediency. It can be quickly performed at the bedside by experienced clinicians. It it has been shown to reliably and accurately diagnose patients with a variety of lung diseases, including pneumonia. This study seeks to investigate the role of lung ultrasound in caring for Covid-19 positive patients and whether it can be used to predict patient deterioration. This information will be vital for healthcare workers who seek to identify the virus or patients at risk for deterioration early in the disease course. Moreover, it has the potential to reduce the need for x-rays or CTs for Covid-19 patients, which has the potential to alleviate a significant burden currently being placed on the healthcare system.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Lung ultrasound will be performed on patients undergoing investigation for covid-19 based on a nasopharyngeal PCR.
Time frame: 28 days from initial evaluation
Composite primary outcome of death, ICU admission, mechanical ventilation, or use of high-flow nasal cannula (categorical)
Time frame: 28 days from initial evaluation
Time frame: 28 days from initial evaluation
Time frame: 28 days from initial evaluation
Time frame: 28 days from initial evaluation
Duration of Hospitalization (days)
Time frame: 28 days from initial evaluation
Descriptive analysis of ultrasound findings in Covid-19
Stanford University
Other
Acronym: POCUS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05321433
COVID-19, Coronaviridae Infections
Solna, Stockholm County, Sweden
View Trial DetailsNCT04914832
COVID-19, Coronaviridae Infections
Mbabane, Eswatini
View Trial DetailsNCT05808361
COVID-19, Coronaviridae Infections
Moscow, Russia
View Trial DetailsNCT04764422
COVID-19, COVID-19 Vaccine
Bangkok, Thailand
View Trial Details